Katleen Verleysen is the founder of miDiagnostics. miDiagnostics has raised $180M in total funding. Latest round: Series D. Based in Leuven, Belgium.
Katleen Verleysen is the CEO of miDiagnostics, a company focused on advancing healthcare through innovative silicon chip technology. miDiagnostics delivers miniaturized, rapid, and user-friendly lab-quality tests directly to patients and clinicians. The company recently secured a €30 million Series D funding round led by Thermo Fisher Scientific to advance a sterility test and other quality control tests for the BioPharma Industry.
Full founder directory · Investor directory · Company funding database · Fundraising library